| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017126 |
| Receipt No. | R000016002 |
| Official scientific title of the study | Reversal of Neuromuscular Blockade with Sugammadex Based on the Residual of Rocuronium in the Body |
| Date of disclosure of the study information | 2015/04/13 |
| Last modified on | 2018/04/16 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Reversal of Neuromuscular Blockade with Sugammadex Based on the Residual of Rocuronium in the Body | |
| Title of the study (Brief title) | Reversal of Neuromuscular Blockade with Sugammadex Based on the Residual of Rocuronium in the Body | |
| Region |
|
|
| Condition | ||
| Condition | Patients scheduled for elective surgery requiring general anesthesia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of the reversal of the neuromuscular blockade with sugammadex which dose was calculated from the residual of rocuronium using pharmacokinetic simulation |
| Basic objectives2 | PK,PD |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluation of neuromuscular responses with a peripheral neurostimulator |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Single blind -participants are blinded |
| Control | Dose comparison |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | the group in which sugammadex are administered 2mg/kg | |
| Interventions/Control_2 | the group in which sugammadex are administered 4 times the residual amount of rocuronium | |
| Interventions/Control_3 | the group in which sugammadex are administered 6 times the residual amount of rocuronium | |
| Interventions/Control_4 | the group in which sugammadex are administered 8 times the residual amount of rocuronium | |
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | the patients scheduled for elective surgery requiring general anesthesia
the patients were ASA physical status 1-2 |
|||
| Key exclusion criteria | the patients were ASA physical status 3-4
the patients who have cardiac, hepatic, renal or neuromuscular disorders the patients who are scheduled hepatic or renal surgery |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Satoshi Shibuta |
| Organization | Osaka University Graduate School of Medicine |
| Division name | Department of Anesthesiology and Intensive Care |
| Address | 2-2, Yamadaoka, Suita-shi, Osaka, Japan |
| TEL | +81-6-6879-3133 |
| shibuta@anes.med.osaka-u.ac.jp | |
| Public contact | |
| Name of contact person | Tomotaka Morita |
| Organization | Osaka University Graduate School of Medicine |
| Division name | Department of Anesthesiology and Intensive Care |
| Address | 2-2, Yamadaoka, Suita-shi, Osaka, Japan |
| TEL | +81-6-6879-3133 |
| Homepage URL | |
| tmorita@anes.med.osaka-u.ac.jp | |
| Sponsor | |
| Institute | Department of Anesthesiology and Intensive Care, Osaka University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016002 |